Kidney and urologic disease status update: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 3: | Line 3: | ||
System leader: '''[[User:Maneesha Nandimandalam|Maneesha Nandimandalam, MD]]''' | System leader: '''[[User:Maneesha Nandimandalam|Maneesha Nandimandalam, MD]]''' | ||
== Status Updates == | ==Status Updates== | ||
{| border="1" cellpadding="5" cellspacing="0" align="center" | | {| class="wikitable" border="1" cellpadding="5" cellspacing="0" align="center" |class="wikitable" | ||
|+ | |+ | ||
! colspan="2" style="background:#efefef;" | ! colspan="2" style="background:#efefef;" |Resident survival guide Progress | ||
|- | |- | ||
|Completed | |Completed | ||
| 10 | |10 | ||
|- | |- | ||
|In progress | |In progress | ||
| 6 | |6 | ||
|- | |- | ||
|Remaining | |Remaining | ||
| 5 | |5 | ||
|- | |- | ||
! colspan="2" style="background:#efefef;" | ! colspan="2" style="background:#efefef;" |Primary care chapter Progress | ||
|- | |- | ||
|Completed | |Completed | ||
| | | | ||
|- | |- | ||
|In progress | |In progress | ||
| | | | ||
|- | |- | ||
|Remaining | |Remaining | ||
| | | | ||
|} | |} | ||
Line 34: | Line 34: | ||
! colspan="3" |Primary care resident survival guides | ! colspan="3" |Primary care resident survival guides | ||
|- | |- | ||
! Specialty | !Specialty | ||
! Topic | !Topic | ||
!Author | |||
!Status | |||
!Resident Survival Guide Page | |||
!Author | !Author | ||
!Status | !Status | ||
|- | |- | ||
| Nephrology || [[Acute kidney injury]] | |Nephrology||[[Acute kidney injury]] | ||
| | | | ||
| ||[[Acute kidney failure resident survival guide]]|| Kanwal Khmuani ||Needs some review | | ||[[Acute kidney failure resident survival guide]]||Kanwal Khmuani||Needs some review | ||
|- | |- | ||
| Nephrology || [[Acidosis]] | |Nephrology||[[Acidosis]] | ||
| | | | ||
| ||[[Acidosis resident survival guide]]|| ||P | | ||[[Acidosis resident survival guide]]|| ||P | ||
|- | |- | ||
| Nephrology ||[[Alkalosis]] | |Nephrology||[[Alkalosis]] | ||
| | | | ||
| ||[[Alkalosis resident survival guide]]|| || | | ||[[Alkalosis resident survival guide]]|| || | ||
|- | |- | ||
| Nephrology || [[Hyperkalemia]] | |Nephrology||[[Hyperkalemia]] | ||
| | | | ||
| ||[[Hyperkalemia resident survival guide]]|| Mahmoud ||Complete | | ||[[Hyperkalemia resident survival guide]]||Mahmoud||Complete | ||
|- | |- | ||
| Nephrology || [[Hypokalemia]] | |Nephrology||[[Hypokalemia]] | ||
| | | | ||
| ||[[Hypokalemia resident survival guide]]|| ||Complete | | ||[[Hypokalemia resident survival guide]]|| ||Complete | ||
|- | |- | ||
| Nephrology || [[Hypernatremia]] | |Nephrology||[[Hypernatremia]] | ||
| | | | ||
| ||[[Hypernatremia resident survival guide]]|| Mounika (Ahmed's scholar) ||Needs some review | | ||[[Hypernatremia resident survival guide]]||Mounika (Ahmed's scholar)||Needs some review | ||
|- | |- | ||
| Nephrology || [[Hyponatremia]] | |Nephrology||[[Hyponatremia]] | ||
| | | | ||
| ||[[Hyponatremia resident survival guide]]|| Priyamvada ||Complete | | ||[[Hyponatremia resident survival guide]]||Priyamvada||Complete | ||
|- | |- | ||
| Nephrology || [[Metabolic acidosis]] | |Nephrology||[[Metabolic acidosis]] | ||
| | | | ||
| ||[[Metabolic acidosis resident survival guide]]|| Ogheneochuko ||Complete | | ||[[Metabolic acidosis resident survival guide]]||Ogheneochuko||Complete | ||
|- | |- | ||
| Nephrology || [[Metabolic alkalosis]] | |Nephrology||[[Metabolic alkalosis]] | ||
| | | | ||
| ||[[Metabolic alkalosis resident survival guide]]|| || | | ||[[Metabolic alkalosis resident survival guide]]|| || | ||
|- | |- | ||
| Nephrology || [[Respiratory acidosis]] | |Nephrology||[[Respiratory acidosis]] | ||
| | | | ||
| ||[[Respiratory acidosis resident survival guide]]|| Qasim Khurshid || | | ||[[Respiratory acidosis resident survival guide]]||Qasim Khurshid|| | ||
|- | |- | ||
| Nephrology || [[Respiratory alkalosis]] | |Nephrology||[[Respiratory alkalosis]] | ||
| | | | ||
| ||[[Respiratory alkalosis resident survival guide]]|| || | | ||[[Respiratory alkalosis resident survival guide]]|| || | ||
|- | |- | ||
| Nephrology ||[[Nephrolithiasis]] | |Nephrology||[[Nephrolithiasis]] | ||
| | | | ||
| ||[[Nephrolithiasis resident survival guide]]|| ||Complete | | ||[[Nephrolithiasis resident survival guide]]|| ||Complete | ||
Line 98: | Line 98: | ||
|In progress | |In progress | ||
|- | |- | ||
| Nephrology || [[Polyuria]] | |Nephrology||[[Polyuria]] | ||
| | | | ||
| ||[[Polyuria resident survival guide]]||Zaida | | ||[[Polyuria resident survival guide]]||Zaida | ||
|In progress | |In progress | ||
|- | |- | ||
| Nephrology ||[[Renal artery stenosis]] | |Nephrology||[[Renal artery stenosis]] | ||
| | | | ||
| ||[[Renal artery stenosis resident survival guide]]||Karol||Complete | | ||[[Renal artery stenosis resident survival guide]]||Karol||Complete | ||
Line 157: | Line 157: | ||
|Nephrology | |Nephrology | ||
|[[Edema generalized|Edema]] | |[[Edema generalized|Edema]] | ||
| | |Mydah | ||
| | |In progress | ||
|[[Edema resident survival guide]] | |[[Edema resident survival guide]] | ||
|Sara zand | |Sara zand | ||
Line 182: | Line 182: | ||
==Status Update== | ==Status Update== | ||
{| border="1" cellpadding="5" cellspacing="0" align="center" | | {| class="wikitable" border="1" cellpadding="5" cellspacing="0" align="center" |class="wikitable" | ||
|+ | |+ | ||
! colspan="2" style="background:#efefef;" | ! colspan="2" style="background:#efefef;" |Progress | ||
|- | |- | ||
|Completed | |Completed | ||
|35 | |35 | ||
|- | |- | ||
|In progress | |In progress | ||
|4 | |4 | ||
|- | |- | ||
|Remaining | |Remaining | ||
|37 | |37 | ||
|} | |} | ||
== List of Chapters Requiring Content == | ==List of Chapters Requiring Content== | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | {| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Category}} | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Chapters that need content}} | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Assignment Status}} | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Scholar's name}} | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Coach name}} | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Completion Status}} | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Review status}} | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Reviewer name}} | ||
|- | |- | ||
| rowspan="41" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Kidney diseases | | rowspan="41" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Kidney diseases | ||
Line 219: | Line 219: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Acute uric acid nephropathy | *Acute uric acid nephropathy | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 228: | Line 228: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Albuminuria | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 237: | Line 237: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Balkan nephropathy | *Balkan nephropathy | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 246: | Line 246: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Bartter syndrome | *Bartter syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Tayyaba Ali | | style="padding: 5px 5px; background: #F5F5F5;" |Tayyaba Ali | ||
Line 255: | Line 255: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Beer potomania | *Beer potomania | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 264: | Line 264: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Boyd-Stearns syndrome | *Boyd-Stearns syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 273: | Line 273: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Branchio-oto-renal syndrome | *Branchio-oto-renal syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 282: | Line 282: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Continuous veno-venous hemofiltration | *Continuous veno-venous hemofiltration | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 291: | Line 291: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Calix diverticulum | *Calix diverticulum | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 300: | Line 300: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Contrast-induced acute kidney injury | *Contrast-induced acute kidney injury | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 309: | Line 309: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Cholesterol emboli syndrome | *Cholesterol emboli syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Abdul | | style="padding: 5px 5px; background: #F5F5F5;" |Abdul | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Ahmed Elsaiey | | style="padding: 5px 5px; background: #F5F5F5;" |Ahmed Elsaiey | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 318: | Line 318: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Crush syndrome | *Crush syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 327: | Line 327: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* C4 glomerulopathy | *C4 glomerulopathy | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |{{Norina Usman}} | | style="padding: 5px 5px; background: #F5F5F5;" |{{Norina Usman}} | ||
Line 336: | Line 336: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Dent's disease | *Dent's disease | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 345: | Line 345: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Dialysis (LP) | *Dialysis (LP) | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 354: | Line 354: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Diuresis | *Diuresis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 363: | Line 363: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Fibrillary immunotactoid glomerulopathy | *Fibrillary immunotactoid glomerulopathy | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 381: | Line 381: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Hypophosphatemia | *Hypophosphatemia | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 390: | Line 390: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Haff disease | *Haff disease | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 399: | Line 399: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Hemodialysis (SP) | *Hemodialysis (SP) | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 408: | Line 408: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Hypertensive nephropathy | *Hypertensive nephropathy | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Nasrin | | style="padding: 5px 5px; background: #F5F5F5;" |Nasrin | ||
Line 417: | Line 417: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Kidney transplantation | *Kidney transplantation | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 426: | Line 426: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Multicystic dysplastic kidney | *Multicystic dysplastic kidney | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 436: | Line 436: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Nephroptosis | *Nephroptosis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 446: | Line 446: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Nutcracker syndrome | *Nutcracker syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 456: | Line 456: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Papillorenal syndrome | *Papillorenal syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 465: | Line 465: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Peritoneal dialysis (SP) | *Peritoneal dialysis (SP) | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 474: | Line 474: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Phosphate nephropathy | *Phosphate nephropathy | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assingned | | style="padding: 5px 5px; background: #F5F5F5;" |Assingned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Ayesha FJ | | style="padding: 5px 5px; background: #F5F5F5;" |Ayesha FJ | ||
Line 483: | Line 483: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Pyonephrosis | *Pyonephrosis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 492: | Line 492: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Rhabdomyolysis | *Rhabdomyolysis | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assingned | | style="padding: 5px 5px; background: #F5F5F5;" |Assingned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Ayesha FJ, | | style="padding: 5px 5px; background: #F5F5F5;" |Ayesha FJ, | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Sogand | | style="padding: 5px 5px; background: #F5F5F5;" |Sogand | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 501: | Line 501: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Rebound diuresis | *Rebound diuresis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 518: | Line 518: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Renal artery stenosis | *Renal artery stenosis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 528: | Line 528: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Renal papillary necrosis | *Renal papillary necrosis | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
Line 538: | Line 538: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Thin basement membrane disease | *Thin basement membrane disease | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 885: | Line 885: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Yes | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Done | | style="padding: 5px 5px; background: #F5F5F5;" |Done | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian | | style="padding: 5px 5px; background: #F5F5F5;" |Mehrian | ||
|- | |- | ||
|- | |- | ||
Line 984: | Line 984: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Hydronephrosis | | style="padding: 5px 5px; background: #F5F5F5;" |Hydronephrosis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Chandra | | style="padding: 5px 5px; background: #F5F5F5;" |Chandra |
Revision as of 14:45, 30 August 2020
Organ System Project |
---|
Topics |
Leaders & Members |
Meetings' Summary |
System leader: Maneesha Nandimandalam, MD
Status Updates
Resident survival guide Progress | |
---|---|
Completed | 10 |
In progress | 6 |
Remaining | 5 |
Primary care chapter Progress | |
Completed | |
In progress | |
Remaining |
Primary Care Topics
Status Update
Progress | |
---|---|
Completed | 35 |
In progress | 4 |
Remaining | 37 |
List of Chapters Requiring Content
Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
Kidney diseases | |||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
Assigned | Tayyaba Ali | Huda | ||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
Assigned | Abdul | Ahmed Elsaiey | ||||
|
|||||||
|
Assigned | Norina Usman, M.B.B.S[1] | Aditya Ganti M.B.B.S. [2] | ||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
Assigned | Nasrin | Elsaiey,Ahmed | ||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
Assingned | Ayesha FJ | Sogand | ||||
|
|||||||
|
Assingned | Ayesha FJ, | Sogand | ||||
|
|||||||
|
Assigned | Shakiba | Elsaiey,Ahmed | ||||
|
|||||||
|
Assigned | Nasrin | Elsaiey,Ahmed | ||||
|
In progress chapters
Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
Kidney diseases | Cardiorenal syndrome | Assigned | Dina | Huda | |||
Analgesic nephropathy | Assigned | Shakiba | Elsaiey,Ahmed | Yes | Not done | ||
HIV associated nephropathy | Assigned | Shakiba | Elsaiey,Ahmed | Yes | Not done | ||
Milk-alkali syndrome | Assigned | Shakiba | Elsaiey,Ahmed | Yes | Not done | ||
Bartter syndrome | Assigned | Tayyaba | Huda | Yes | Not done | ||
Completed chapters
Category | Chapters | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
Kidney diseases | Electrolyte imbalance (LP) | Mehdi | Yes | Done | Mehrian | ||
Hyponatremia | Saeedeh | Yes | Done | Mahshid | |||
Hypernatremia | Feham | Yes | Done | Elsaiey | |||
Hypokalemia | Rc-Aida | Yes | Done | Mahshid | |||
Hyperkalemia | Jogeet | Yes | Done | Amandeep | |||
Hypocalcemia | Krishna | Yes | Done | Hasan | |||
Hypercalcemia | Anmol | Yes | Done | Sudarshana Datta | |||
Glomerular Disease(LP) | Mehrian | Yes | Done | Farima | |||
Lupus Nephritis | Aida/ Omer | Yes | Done | Iqra | |||
Rapidly progressive glomerulonephritis | Nazia / Jogeet | Yes | Done | Aditya | |||
Membranous glomerulonephritis | Sunny/ Seyd | Yes | Done | Amandeep | |||
Membranoproliferative glomerulonephritis | rc Arash | Yes | Done | Aditya | |||
IgA nephropathy | Dildar | Yes | Done | Mehrian | |||
Goodpasture syndrome | Akshun | Yes | Done | Farima | |||
Amyloidosis (LP) | Shamila | Yes | Done | Mehrian | |||
Primary amyloidosis | |||||||
Secondary amyloidosis | |||||||
Familial amyloidosis | |||||||
Wild-type(senile) amyloidosis | |||||||
Cardiac amyloidosis | |||||||
Beta-2 microglobulin related amyloidosis | |||||||
Gelsolin related amyloidosis | |||||||
C3 glomerulopathy | Vindhya | Yes | Done | ||||
Bladder cancer | Farima Kahe | Yes | Done | ||||
Hydronephrosis | Chandra | Yes | Done | Aditya | |||
Kidney stone | Amandeep | Yes | Done | Aditya | |||
Polycystic kidney disease | Khurram | Yes | Done | Anmol | |||
Nephritic syndrome | Dildar | Yes | Done | Mehrian | |||
Nephrotic syndrome | Mehrian | Yes | Done | Sadaf | |||
Post-streptococcal glomerulonephritis | Manpreet | Yes | Done | Mehrian | |||
Renal cell carcinoma | Farima | Yes | Done | Anmol | |||
Renal osteodystrophy | |||||||
Renal tubular acidosis | Aditya | Yes | Done | Sargun | |||
Renal vein thrombosis | Saeedeh | Yes | Done | Mehdi | |||
Wilms' tumor | Sargun | Yes | Done | Farima |